GSK To Buy Nuvalent For $10.6 Billion In Cancer Drug Drive
GSK to buy Nuvalent for $10.6 billion; Fevertree reaps rewards from US partnership
By Louise Moon ยท Bloomberg
GSK to buy Nuvalent for $10.6 billion; Fevertree reaps rewards from US partnership